RC-402 is under clinical development by Virocure and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase I drugs for Metastatic Colorectal Cancer have an 84% phase ...

Cancer remission can be partial, complete, or spontaneous. For cancer to be in remission, a decrease in cancer signs for at least a month must be observed. Cancers in remission, however, may come ...

Background: There has been limited success of cancer immunotherapies in the treatment of ovarian cancer (OvCa) to date, largely due to the immunosuppressive tumour microenvironment (TME).

Bone cancer is when cells in your bones grow out of control. Usually, when you have bone cancer, it comes from another cancer that has spread to your bones or metastatic bone cancer. But ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

metastatic colorectal cancer and unresectable anal cancer. The drug candidate is administered as injection or infusion through intravenous, intralesional, intratumoral, intraperitoneal and intrathecal ...

Peritoneal cancer, also called primary peritoneal cancer, is a rare type of cancer, occurring in fewer than seven out of every million people in the United States. The peritoneum is a membrane that ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.